# PRESERVE-MITRAL Post-Market Registry

> **NCT03283722** · — · COMPLETED · sponsor: **Medtronic Cardiac Surgery** · enrollment: 200 (actual)

## Conditions studied

- Mitral Valve Disease

## Interventions

- **DEVICE:** Profile 3D™ and CG Future® annuloplasty system

## Key facts

- **NCT ID:** NCT03283722
- **Lead sponsor:** Medtronic Cardiac Surgery
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-10
- **Primary completion:** 2021-02-10
- **Final completion:** 2021-02-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03283722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03283722, "PRESERVE-MITRAL Post-Market Registry". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03283722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*